|
ERCC6L expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.742000E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.961860E-02 |
| Normal-vs-Stage2 |
9.195400E-01 |
| Normal-vs-Stage3 |
9.136000E-02 |
| Normal-vs-Stage4 |
1.311780E-02 |
| Stage1-vs-Stage2 |
2.201200E-03 |
| Stage1-vs-Stage3 |
2.883200E-01 |
| Stage1-vs-Stage4 |
4.307600E-01 |
| Stage2-vs-Stage3 |
2.936200E-02 |
| Stage2-vs-Stage4 |
2.022700E-03 |
| Stage3-vs-Stage4 |
1.472390E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.351900E-02 |
| Normal-vs-AfricanAmerican |
1.555160E-01 |
| Normal-vs-Asian |
1.042420E-02 |
| Caucasian-vs-AfricanAmerican |
7.020800E-01 |
| Caucasian-vs-Asian |
3.388000E-01 |
| AfricanAmerican-vs-Asian |
3.266800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.985700E-02 |
| Normal-vs-Female |
4.249800E-02 |
| Male-vs-Female |
7.814200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.375600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.327400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.599780E-01 |
| Normal-vs-Age(81-100Yrs) |
1.002810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.575100E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.343500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.269200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.788000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.954000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.664570E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.964600E-01 |
| Classical-VS-Follicular |
1.08570041845724E-10 |
| Classical-VS-Other |
2.044600E-01 |
| Classical-VS-Normal |
4.540800E-03 |
| Tall-VS-Follicular |
2.017300E-04 |
| Tall-VS-Other |
2.247600E-01 |
| Tall-VS-Normal |
2.524200E-02 |
| Follicular-VS-Other |
4.218800E-01 |
| Follicular-VS-Normal |
7.043200E-01 |
| Other-VS-Normal |
6.071000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.951230E-01 |
| Normal-vs-N1 |
1.414480E-02 |
| N0-vs-N1 |
4.691800E-02 |
|
|
